Koji Sasaki

173PUBLICATIONS
322CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (173)

|Aug 17, 2026
Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 10, 2026
Germ line landscape stratification defines distinct molecular and prognostic groups in therapy-related myeloid neoplasms.

|Jun 22, 2026
Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Apr 14, 2026
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

Pageof 29

Frequent Collaborators

94 joint publications

Tapan M Kadia

90 joint publications

Naval G Daver

89 joint publications

Nicholas Short

85 joint publications

Hagop M Kantarjian